CSI Market
Sign In | Register

Morphosys Ag (MOR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MOR Annual Cash Flow →
Reviewing cash flow figures over time highlights how Morphosys Ag balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		0 0 0 (Dec 31 2022)
Operating Activities
Income-212.50
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss24.95
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Purchase Of Availableforsale Financial Assets-3,529.31
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Adjustments For Depreciation And Amortisation Expense-
Adjustment In Net Gain Loss On Sales Of Financial Assets At Fair Value Through Profit Or Loss-
Adjustmentinnetgainlossonsalesoffinancialassetsatamortizedcost-
Adjustmentinimpairmentlossreversalofimpairmentlossrecognisedonfinancialassets-
Non Cash Effective Net Changes In Financial Assets Or Financial Liabilities From Collaborations-
Non Cash Effective Change Of Finanical Liabilities Ayt Amortized Cost-
Reversal Of Impairment Loss Recognised In Profit Or Loss-
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates-
Adjustments For Decrease Increase In Other Operating Receivables-
Adjustments For Decrease Increase In Accounts Payable And Accruals Tax Provisions And Other Provisions-
Adjustments For Increase Decrease In Other Liabilities-
Adjustments For Increase Decrease In Deferred Income-
Income Taxes Paid Classified As Operating Activities-
Income taxes0.00
Losses/ -gains on Investments net3,521.37
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Other Adjustments To Reconcile Profit Loss4.25
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities74.31
Discontinued operations0.00
Net Cash flow from Operating Activities-331.34
Investing Activities
Capital Expenditures-0.39
Sale of Capital Items0.00
Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Derivative Financial Instruments-
Interest Received Classified As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Purchase Of Financial Instruments Classified As Investing Activities0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash FlowsFrom Losing Control Of Subsidiaries OrOther Businesses Classified As Investing Activities0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-2.80
Discontinued operations0.00
Net Cash Flow from Investing Activities17.22
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-2.67
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net323.94
Increase Decrease In Cash And Cash Equivalents-
Proceeds From Issue Of Bonds Notes And Debentures-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities48.16
Effect of exchange rate on cash flow-7.15
Discontinued operations0.00
Free Cash Flow-331.73
Total Cash Flow450.63
4 historic quarters locked

Sign in to unlock the full Morphosys Ag cash flow history.

Sign In Create Free Account

About Morphosys Ag Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20231231)
  • Filed with the SEC: March 13, 2024
  • Source: mor-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-24-010887

Figures are derived from filed reports and may be restated. Historical data is subject to revision.